Search Results for: Influenza

1761 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
ACTN2 and RPL35 actinin, alpha 2 ribosomal protein L35
  • Striated Muscle Contraction
  • Platelet degranulation
  • CREB phosphorylation through the activation of Ras
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • Response to elevated platelet cytosolic Ca2+
  • CREB phosphorylation through the activation of CaMKII
  • Nephrin interactions
  • Platelet activation, signaling and aggregation
  • Unblocking of NMDA receptor, glutamate binding and activation
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Transmission across Chemical Synapses
  • Post NMDA receptor activation events
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
ACVR1 and UBA52 activin A receptor, type I ubiquitin A-52 residue ribosomal protein fusion product 1
  • Loss of Function of TGFBR2 in Cancer
  • NF-kB is activated and signals survival
  • Hedgehog 'off' state
  • Signaling by FGFR in disease
  • Influenza Life Cycle
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Glucose metabolism
  • Signaling by NOTCH1
  • Signaling by NOTCH2
  • Toll Like Receptor 5 (TLR5) Cascade
  • S33 mutants of beta-catenin aren't phosphorylated
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • Stabilization of p53
  • Removal of licensing factors from origins
  • Switching of origins to a post-replicative state
  • Downregulation of ERBB2:ERBB3 signaling
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • Signaling by NOTCH
  • Endosomal Sorting Complex Required For Transport (ESCRT)
  • Spry regulation of FGF signaling
  • Influenza Infection
  • Signaling by NOTCH
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • Regulation of innate immune responses to cytosolic DNA
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Toll Like Receptor 3 (TLR3) Cascade
  • Metabolism of carbohydrates
  • CDK-mediated phosphorylation and removal of Cdc6
  • Cellular response to hypoxia
  • Hedgehog ligand biogenesis
  • p75NTR recruits signalling complexes
  • Fanconi Anemia pathway
  • Separation of Sister Chromatids
  • APC truncation mutants have impaired AXIN binding
  • HIV Infection
  • Peptide chain elongation
  • Assembly of the pre-replicative complex
  • Activated TLR4 signalling
  • Synthesis And Processing Of GAG, GAGPOL Polyproteins
  • S37 mutants of beta-catenin aren't phosphorylated
  • p53-Dependent G1 DNA Damage Response
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • regulation of FZD by ubiquitination
  • Signaling by NOTCH1
  • p53-Independent DNA Damage Response
  • MyD88:Mal cascade initiated on plasma membrane
  • Stimuli-sensing channels
  • p53-Independent G1/S DNA damage checkpoint
  • Membrane binding and targetting of GAG proteins
  • G1/S DNA Damage Checkpoints
  • Downregulation of ERBB4 signaling
  • Vpu mediated degradation of CD4
  • Cell death signalling via NRAGE, NRIF and NADE
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Eukaryotic Translation Termination
  • M/G1 Transition
  • p75 NTR receptor-mediated signalling
  • Signaling by FGFR
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signaling by NOTCH1 in Cancer
  • TCF dependent signaling in response to WNT
  • SCF-beta-TrCP mediated degradation of Emi1
  • degradation of AXIN
  • Degradation of GLI1 by the proteasome
  • Cell Cycle Checkpoints
  • degradation of DVL
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Regulation of Apoptosis
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • Vif-mediated degradation of APOBEC3G
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Downregulation of TGF-beta receptor signaling
  • truncated APC mutants destabilize the destruction complex
  • Cyclin E associated events during G1/S transition
  • TGF-beta receptor signaling activates SMADs
  • Regulation of PLK1 Activity at G2/M Transition
  • FCERI mediated NF-kB activation
  • Generic Transcription Pathway
  • Regulation of the Fanconi anemia pathway
  • G1/S Transition
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Toll Like Receptor 9 (TLR9) Cascade
  • IRAK1 recruits IKK complex
  • truncations of AMER1 destabilize the destruction complex
  • Negative regulation of FGFR signaling
  • EGFR downregulation
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • Translation
  • IRAK2 mediated activation of TAK1 complex
  • Processing-defective Hh variants abrogate ligand secretion
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Host Interactions of HIV factors
  • Signaling by ERBB4
  • Antiviral mechanism by IFN-stimulated genes
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Fc epsilon receptor (FCERI) signaling
  • Interleukin-3, 5 and GM-CSF signaling
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • APC truncation mutants are not K63 polyubiquitinated
  • M Phase
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • HIV Life Cycle
  • Budding and maturation of HIV virion
  • Hedgehog 'on' state
  • Programmed Cell Death
  • Class I MHC mediated antigen processing & presentation
  • IKK complex recruitment mediated by RIP1
  • MAP kinase activation in TLR cascade
  • Regulation of DNA replication
  • Cytokine Signaling in Immune system
  • MyD88-independent cascade
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Viral mRNA Translation
  • Cell Cycle, Mitotic
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Oxidative Stress Induced Senescence
  • Activation of NF-kappaB in B cells
  • Asymmetric localization of PCP proteins
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
  • Formation of a pool of free 40S subunits
  • TRAF6 mediated induction of TAK1 complex
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
  • Negative regulators of RIG-I/MDA5 signaling
  • misspliced GSK3beta mutants stabilize beta-catenin
  • Hh ligand biogenesis disease
  • Cellular Senescence
  • T41 mutants of beta-catenin aren't phosphorylated
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by EGFRvIII in Cancer
  • Downstream signaling events of B Cell Receptor (BCR)
  • Assembly Of The HIV Virion
  • Degradation of beta-catenin by the destruction complex
  • Influenza Viral RNA Transcription and Replication
  • NOD1/2 Signaling Pathway
  • MyD88 dependent cascade initiated on endosome
  • Glycogen storage diseases
  • Cap-dependent Translation Initiation
  • Mitotic G1-G1/S phases
  • activated TAK1 mediates p38 MAPK activation
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • TRIF-mediated TLR3/TLR4 signaling
  • DNA Replication Pre-Initiation
  • Senescence-Associated Secretory Phenotype (SASP)
  • S45 mutants of beta-catenin aren't phosphorylated
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • TGFBR1 KD Mutants in Cancer
  • Regulation of APC/C activators between G1/S and early anaphase
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Late Phase of HIV Life Cycle
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • NOTCH2 Activation and Transmission of Signal to the Nucleus
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • TCR signaling
  • AMER1 mutants destabilize the destruction complex
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • Interleukin-1 signaling
  • Eukaryotic Translation Elongation
  • PCP/CE pathway
  • Mitotic G2-G2/M phases
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Adaptive Immune System
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Ubiquitin-dependent degradation of Cyclin D
  • G2/M Transition
  • Oncogene Induced Senescence
  • TGFBR1 LBD Mutants in Cancer
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • Ion channel transport
  • Eukaryotic Translation Initiation
  • p75NTR signals via NF-kB
  • Regulation of signaling by CBL
  • Disease
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Signal Transduction
  • Innate Immune System
  • Nonsense-Mediated Decay (NMD)
  • Synthesis of DNA
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • G1 Phase
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Ubiquitin-dependent degradation of Cyclin D1
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Toll-Like Receptors Cascades
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Cyclin D associated events in G1
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Regulation of mitotic cell cycle
  • Signaling by Hedgehog
  • Association of licensing factors with the pre-replicative complex
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • TCF7L2 mutants don't bind CTBP
  • p53-Dependent G1/S DNA damage checkpoint
  • Signaling by Wnt
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • APC/C:Cdc20 mediated degradation of Securin
  • AUF1 (hnRNP D0) destabilizes mRNA
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • CDK-mediated phosphorylation and removal of Cdc6
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • IRAK1 recruits IKK complex
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • RNF mutants show enhanced WNT signaling and proliferation
  • Myoclonic epilepsy of Lafora
  • Signaling by NOTCH1 in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • IRAK2 mediated activation of TAK1 complex
  • SRP-dependent cotranslational protein targeting to membrane
  • Loss of Function of SMAD4 in Cancer
  • AXIN missense mutants destabilize the destruction complex
  • S Phase
  • APC/C-mediated degradation of cell cycle proteins
  • Signaling by ERBB2
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by EGFR
  • Signaling by Interleukins
  • Glycogen synthesis
  • NRIF signals cell death from the nucleus
  • Toll Like Receptor 4 (TLR4) Cascade
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by EGFR in Cancer
  • SCF(Skp2)-mediated degradation of p27/p21
  • Cyclin A:Cdk2-associated events at S phase entry
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Mitotic Metaphase and Anaphase
  • Downstream TCR signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Orc1 removal from chromatin
  • Mitotic Anaphase
  • deactivation of the beta-catenin transactivating complex
  • Toll Like Receptor TLR6:TLR2 Cascade
  • MyD88 cascade initiated on plasma membrane
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Signalling by NGF
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Cytosolic sensors of pathogen-associated DNA
  • beta-catenin independent WNT signaling
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Orc1 removal from chromatin
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Signaling by TGF-beta Receptor Complex
  • CDT1 association with the CDC6:ORC:origin complex
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • SMAD4 MH2 Domain Mutants in Cancer
  • Adenosine triphosphate
  • 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine
ACVR1 and RPS27A activin A receptor, type I ribosomal protein S27a
  • Loss of Function of TGFBR2 in Cancer
  • NF-kB is activated and signals survival
  • Hedgehog 'off' state
  • Signaling by FGFR in disease
  • Influenza Life Cycle
  • Glucose metabolism
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Signaling by NOTCH1
  • Signaling by NOTCH2
  • Toll Like Receptor 5 (TLR5) Cascade
  • S33 mutants of beta-catenin aren't phosphorylated
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • Stabilization of p53
  • Removal of licensing factors from origins
  • Switching of origins to a post-replicative state
  • Downregulation of ERBB2:ERBB3 signaling
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • Signaling by NOTCH
  • Endosomal Sorting Complex Required For Transport (ESCRT)
  • Spry regulation of FGF signaling
  • Influenza Infection
  • Signaling by NOTCH
  • SCF(Skp2)-mediated degradation of p27/p21
  • deletions in the AMER1 gene destabilize the destruction complex
  • Regulation of innate immune responses to cytosolic DNA
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Toll Like Receptor 3 (TLR3) Cascade
  • Metabolism of carbohydrates
  • CDK-mediated phosphorylation and removal of Cdc6
  • Cellular response to hypoxia
  • Hedgehog ligand biogenesis
  • p75NTR recruits signalling complexes
  • Fanconi Anemia pathway
  • Separation of Sister Chromatids
  • APC truncation mutants have impaired AXIN binding
  • HIV Infection
  • Peptide chain elongation
  • Assembly of the pre-replicative complex
  • Activated TLR4 signalling
  • Synthesis And Processing Of GAG, GAGPOL Polyproteins
  • S37 mutants of beta-catenin aren't phosphorylated
  • p53-Dependent G1 DNA Damage Response
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • regulation of FZD by ubiquitination
  • Signaling by NOTCH1
  • p53-Independent DNA Damage Response
  • MyD88:Mal cascade initiated on plasma membrane
  • Stimuli-sensing channels
  • p53-Independent G1/S DNA damage checkpoint
  • Membrane binding and targetting of GAG proteins
  • G1/S DNA Damage Checkpoints
  • Downregulation of ERBB4 signaling
  • Vpu mediated degradation of CD4
  • Cell death signalling via NRAGE, NRIF and NADE
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Eukaryotic Translation Termination
  • M/G1 Transition
  • p75 NTR receptor-mediated signalling
  • Signaling by FGFR
  • Toll Like Receptor 10 (TLR10) Cascade
  • Signaling by NOTCH1 in Cancer
  • TCF dependent signaling in response to WNT
  • SCF-beta-TrCP mediated degradation of Emi1
  • degradation of AXIN
  • Degradation of GLI1 by the proteasome
  • Cell Cycle Checkpoints
  • degradation of DVL
  • Signaling by WNT in cancer
  • GLI3 is processed to GLI3R by the proteasome
  • Regulation of Apoptosis
  • Degradation of GLI2 by the proteasome
  • Signaling by the B Cell Receptor (BCR)
  • Translation initiation complex formation
  • Vif-mediated degradation of APOBEC3G
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Constitutive Signaling by NOTCH1 HD Domain Mutants
  • Downregulation of TGF-beta receptor signaling
  • truncated APC mutants destabilize the destruction complex
  • Cyclin E associated events during G1/S transition
  • TGF-beta receptor signaling activates SMADs
  • Regulation of PLK1 Activity at G2/M Transition
  • FCERI mediated NF-kB activation
  • Generic Transcription Pathway
  • Regulation of the Fanconi anemia pathway
  • G1/S Transition
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Toll Like Receptor 9 (TLR9) Cascade
  • IRAK1 recruits IKK complex
  • truncations of AMER1 destabilize the destruction complex
  • Negative regulation of FGFR signaling
  • EGFR downregulation
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • Translation
  • IRAK2 mediated activation of TAK1 complex
  • Processing-defective Hh variants abrogate ligand secretion
  • Regulation of activated PAK-2p34 by proteasome mediated degradation
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • Host Interactions of HIV factors
  • Signaling by ERBB4
  • Antiviral mechanism by IFN-stimulated genes
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Fc epsilon receptor (FCERI) signaling
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Interleukin-3, 5 and GM-CSF signaling
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • APC truncation mutants are not K63 polyubiquitinated
  • M Phase
  • Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
  • HIV Life Cycle
  • Budding and maturation of HIV virion
  • Hedgehog 'on' state
  • Programmed Cell Death
  • Class I MHC mediated antigen processing & presentation
  • IKK complex recruitment mediated by RIP1
  • MAP kinase activation in TLR cascade
  • Regulation of DNA replication
  • Cytokine Signaling in Immune system
  • MyD88-independent cascade
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Viral mRNA Translation
  • Cell Cycle, Mitotic
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Oxidative Stress Induced Senescence
  • Activation of NF-kappaB in B cells
  • Asymmetric localization of PCP proteins
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
  • Formation of a pool of free 40S subunits
  • TRAF6 mediated induction of TAK1 complex
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
  • Negative regulators of RIG-I/MDA5 signaling
  • misspliced GSK3beta mutants stabilize beta-catenin
  • Hh ligand biogenesis disease
  • Cellular Senescence
  • T41 mutants of beta-catenin aren't phosphorylated
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by EGFRvIII in Cancer
  • Downstream signaling events of B Cell Receptor (BCR)
  • Assembly Of The HIV Virion
  • Degradation of beta-catenin by the destruction complex
  • Influenza Viral RNA Transcription and Replication
  • NOD1/2 Signaling Pathway
  • MyD88 dependent cascade initiated on endosome
  • Glycogen storage diseases
  • Cap-dependent Translation Initiation
  • Mitotic G1-G1/S phases
  • activated TAK1 mediates p38 MAPK activation
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • TRIF-mediated TLR3/TLR4 signaling
  • DNA Replication Pre-Initiation
  • Senescence-Associated Secretory Phenotype (SASP)
  • S45 mutants of beta-catenin aren't phosphorylated
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • TGFBR1 KD Mutants in Cancer
  • Regulation of APC/C activators between G1/S and early anaphase
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Late Phase of HIV Life Cycle
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • NOTCH2 Activation and Transmission of Signal to the Nucleus
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • TCR signaling
  • AMER1 mutants destabilize the destruction complex
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • Interleukin-1 signaling
  • Eukaryotic Translation Elongation
  • PCP/CE pathway
  • Mitotic G2-G2/M phases
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Adaptive Immune System
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Ubiquitin-dependent degradation of Cyclin D
  • G2/M Transition
  • Oncogene Induced Senescence
  • TGFBR1 LBD Mutants in Cancer
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • Ion channel transport
  • Eukaryotic Translation Initiation
  • p75NTR signals via NF-kB
  • Regulation of signaling by CBL
  • Disease
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • Signal Transduction
  • Innate Immune System
  • Nonsense-Mediated Decay (NMD)
  • Synthesis of DNA
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • G1 Phase
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Ubiquitin-dependent degradation of Cyclin D1
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Toll-Like Receptors Cascades
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Cyclin D associated events in G1
  • Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
  • Regulation of mitotic cell cycle
  • Signaling by Hedgehog
  • Association of licensing factors with the pre-replicative complex
  • IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
  • Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
  • TCF7L2 mutants don't bind CTBP
  • p53-Dependent G1/S DNA damage checkpoint
  • Signaling by Wnt
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • APC/C:Cdc20 mediated degradation of Securin
  • AUF1 (hnRNP D0) destabilizes mRNA
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • CDK-mediated phosphorylation and removal of Cdc6
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • IRAK1 recruits IKK complex
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • RNF mutants show enhanced WNT signaling and proliferation
  • Myoclonic epilepsy of Lafora
  • Signaling by NOTCH1 in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • IRAK2 mediated activation of TAK1 complex
  • SRP-dependent cotranslational protein targeting to membrane
  • Loss of Function of SMAD4 in Cancer
  • AXIN missense mutants destabilize the destruction complex
  • S Phase
  • APC/C-mediated degradation of cell cycle proteins
  • Signaling by ERBB2
  • Toll Like Receptor 2 (TLR2) Cascade
  • Signaling by EGFR
  • Signaling by Interleukins
  • Glycogen synthesis
  • NRIF signals cell death from the nucleus
  • Toll Like Receptor 4 (TLR4) Cascade
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by EGFR in Cancer
  • SCF(Skp2)-mediated degradation of p27/p21
  • Cyclin A:Cdk2-associated events at S phase entry
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Mitotic Metaphase and Anaphase
  • Downstream TCR signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Orc1 removal from chromatin
  • Mitotic Anaphase
  • deactivation of the beta-catenin transactivating complex
  • Toll Like Receptor TLR6:TLR2 Cascade
  • MyD88 cascade initiated on plasma membrane
  • Activated NOTCH1 Transmits Signal to the Nucleus
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • FBXW7 Mutants and NOTCH1 in Cancer
  • Signalling by NGF
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Cytosolic sensors of pathogen-associated DNA
  • beta-catenin independent WNT signaling
  • Ribosomal scanning and start codon recognition
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Orc1 removal from chromatin
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Signaling by TGF-beta Receptor Complex
  • CDT1 association with the CDC6:ORC:origin complex
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • SMAD4 MH2 Domain Mutants in Cancer
  • Adenosine triphosphate
  • 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine
ACVRL1 and TGFB1 activin A receptor type II-like 1 transforming growth factor, beta 1
  • Loss of Function of TGFBR2 in Cancer
  • Elastic fibre formation
  • Downregulation of TGF-beta receptor signaling
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Platelet degranulation
  • TGF-beta receptor signaling activates SMADs
  • Host Interactions with Influenza Factors
  • TGFBR1 LBD Mutants in Cancer
  • Influenza Virus Induced Apoptosis
  • Molecules associated with elastic fibres
  • ECM proteoglycans
  • Response to elevated platelet cytosolic Ca2+
  • Transcriptional regulation of white adipocyte differentiation
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Non-integrin membrane-ECM interactions
  • Influenza Infection
  • Loss of Function of TGFBR1 in Cancer
  • Syndecan interactions
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • Platelet activation, signaling and aggregation
  • SMAD4 MH2 Domain Mutants in Cancer
  • Adenosine triphosphate
  • Hyaluronidase
ADAR and XPO1 adenosine deaminase, RNA-specific exportin 1
  • Formation of editosomes by ADAR proteins
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • mRNA Editing: A to I Conversion
  • C6 deamination of adenosine
  • Interferon alpha/beta signaling
  • mRNA Editing
  • Loss of Function of TGFBR2 in Cancer
  • Downregulation of TGF-beta receptor signaling
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • TGF-beta receptor signaling activates SMADs
  • Influenza Life Cycle
  • Export of Viral Ribonucleoproteins from Nucleus
  • RNF mutants show enhanced WNT signaling and proliferation
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Host Interactions of HIV factors
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Influenza Infection
  • Late Phase of HIV Life Cycle
  • Resolution of Sister Chromatid Cohesion
  • Mitotic G2-G2/M phases
  • Mitotic Metaphase and Anaphase
  • Mitotic Prometaphase
  • Separation of Sister Chromatids
  • HIV Infection
  • Rev-mediated nuclear export of HIV RNA
  • G2/M Transition
  • Mitotic Anaphase
  • TGFBR1 LBD Mutants in Cancer
  • HuR stabilizes mRNA
  • deactivation of the beta-catenin transactivating complex
  • M Phase
  • HIV Life Cycle
  • Rev-mediated nuclear export of HIV RNA
  • Cyclin A/B1 associated events during G2/M transition
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • NEP/NS2 Interacts with the Cellular Export Machinery
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Interactions of Rev with host cellular proteins
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex
  • Signaling by TGF-beta Receptor Complex in Cancer
  • TCF dependent signaling in response to WNT
  • Signaling by WNT in cancer
  • SMAD4 MH2 Domain Mutants in Cancer
ADH4 and RPL35 alcohol dehydrogenase 4 (class II), pi polypeptide ribosomal protein L35
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Metabolic disorders of biological oxidation enzymes
  • Ethanol oxidation
  • Phase 1 - Functionalization of compounds
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Biological oxidations
  • RA biosynthesis pathway
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Signaling by Retinoic Acid
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • Defective CYP1B1 causes Glaucoma
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • NADH
  • Nicotinamide-Adenine-Dinucleotide
  • Cyclohexylformamide
ADH6 and RPS29 alcohol dehydrogenase 6 (class V) ribosomal protein S29
  • Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
  • Defective FMO3 causes Trimethylaminuria (TMAU)
  • Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
  • Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
  • Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
  • Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
  • Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
  • Ethanol oxidation
  • Metabolic disorders of biological oxidation enzymes
  • Defective CYP1B1 causes Glaucoma
  • Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
  • Phase 1 - Functionalization of compounds
  • Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
  • Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
  • Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
  • Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
  • Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
  • Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
  • Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
  • Defective MAOA causes Brunner syndrome (BRUNS)
  • Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
  • Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
  • Biological oxidations
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
PARP1 and RPS3A poly (ADP-ribose) polymerase 1 ribosomal protein S3A
  • Loss of Function of TGFBR2 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • TGFBR1 LBD Mutants in Cancer
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Loss of Function of TGFBR1 in Cancer
  • Generic Transcription Pathway
  • Signaling by TGF-beta Receptor Complex
  • Signaling by TGF-beta Receptor Complex in Cancer
  • SMAD4 MH2 Domain Mutants in Cancer
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Carba-Nicotinamide-Adenine-Dinucleotide
  • NU1025
  • Nicotinamide
  • 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone
  • 3-Methoxybenzamide
  • 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
  • 3,4-Dihydro-5-Methyl-Isoquinolinone
  • 2-(3\'-Methoxyphenyl) Benzimidazole-4-Carboxamide
  • 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE
  • (2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium
  • trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium
  • 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE
PARP1 and GTF2F1 poly (ADP-ribose) polymerase 1 general transcription factor IIF, polypeptide 1, 74kDa
  • Loss of Function of TGFBR2 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • TGFBR1 LBD Mutants in Cancer
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Loss of Function of TGFBR1 in Cancer
  • Generic Transcription Pathway
  • Signaling by TGF-beta Receptor Complex
  • Signaling by TGF-beta Receptor Complex in Cancer
  • SMAD4 MH2 Domain Mutants in Cancer
  • RNA Polymerase II Promoter Escape
  • mRNA Splicing
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • HIV Infection
  • Formation of the Early Elongation Complex
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • Influenza Life Cycle
  • HIV elongation arrest and recovery
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Influenza Viral RNA Transcription and Replication
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Viral Messenger RNA Synthesis
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
  • RNA Polymerase II Transcription Elongation
  • Carba-Nicotinamide-Adenine-Dinucleotide
  • NU1025
  • Nicotinamide
  • 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone
  • 3-Methoxybenzamide
  • 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
  • 3,4-Dihydro-5-Methyl-Isoquinolinone
  • 2-(3\'-Methoxyphenyl) Benzimidazole-4-Carboxamide
  • 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE
  • (2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium
  • trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium
  • 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE
ADRB2 and RAN adrenoceptor beta 2, surface RAN, member RAS oncogene family
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • GPCR downstream signaling
  • G alpha (s) signalling events
  • Adrenoceptors
  • Class A/1 (Rhodopsin-like receptors)
  • Amine ligand-binding receptors
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Transcriptional regulation by small RNAs
  • Metabolism of lipids and lipoproteins
  • Nuclear import of Rev protein
  • HIV Infection
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Host Interactions of HIV factors
  • MicroRNA (miRNA) biogenesis
  • Influenza Infection
  • Interactions of Rev with host cellular proteins
  • Late Phase of HIV Life Cycle
  • Influenza Life Cycle
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Export of Viral Ribonucleoproteins from Nucleus
  • HIV Life Cycle
  • Rev-mediated nuclear export of HIV RNA
  • NEP/NS2 Interacts with the Cellular Export Machinery
  • Betaxolol
  • Metoprolol
  • Norepinephrine
  • Timolol
  • Dipivefrin
  • Sotalol
  • Carteolol
  • Propranolol
  • Labetalol
  • Bisoprolol
  • Epinephrine
  • Orciprenaline
  • Dobutamine
  • Pseudoephedrine
  • Alprenolol
  • Ritodrine
  • Terbutaline
  • Bitolterol
  • Phenoxybenzamine
  • Salmeterol
  • Pindolol
  • Formoterol
  • Salbutamol
  • Isoproterenol
  • Arbutamine
  • Carvedilol
  • Desipramine
  • Acebutolol
  • Nadolol
  • Levobunolol
  • Metipranolol
  • Arformoterol
  • Fenoterol
  • Pirbuterol
  • Bevantolol
  • Penbutolol
  • Ephedra
  • Procaterol
  • Clenbuterol
  • Bambuterol
  • Oxprenolol
  • Nebivolol
  • Indacaterol
  • Asenapine
  • Droxidopa
  • (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol
  • Bopindolol
  • Bupranolol
ADRBK1 and RPLP2 adrenergic, beta, receptor kinase 1 ribosomal protein, large, P2
  • G alpha (q) signalling events
  • Ca-dependent events
  • Signaling by GPCR
  • CaM pathway
  • Phospholipase C-mediated cascade
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • DAG and IP3 signaling
  • CaM pathway
  • DAP12 signaling
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Hedgehog 'on' state
  • Downstream signaling of activated FGFR
  • Innate Immune System
  • Signaling by PDGF
  • Calmodulin induced events
  • Signalling by NGF
  • DAP12 interactions
  • PLC beta mediated events
  • Opioid Signalling
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • EGFR interacts with phospholipase C-gamma
  • Signaling by ERBB2
  • G alpha (q) signalling events
  • Signaling by EGFR
  • GPCR downstream signaling
  • Calmodulin induced events
  • Downstream signal transduction
  • PLC-gamma1 signalling
  • Signaling by Hedgehog
  • Signaling by EGFR in Cancer
  • Activation of SMO
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
  • Adenosine triphosphate
AP2B1 and POM121 adaptor-related protein complex 2, beta 1 subunit POM121 transmembrane nucleoporin
  • Retrograde neurotrophin signalling
  • Axon guidance
  • HIV Infection
  • Nef Mediated CD8 Down-regulation
  • L1CAM interactions
  • Signaling by Wnt
  • Signaling by EGFRvIII in Cancer
  • Recycling pathway of L1
  • EPH-ephrin mediated repulsion of cells
  • MHC class II antigen presentation
  • EPH-Ephrin signaling
  • Nef Mediated CD4 Down-regulation
  • EGFR downregulation
  • Signalling by NGF
  • Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
  • Host Interactions of HIV factors
  • The role of Nef in HIV-1 replication and disease pathogenesis
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • beta-catenin independent WNT signaling
  • Signaling by EGFR
  • WNT5A-dependent internalization of FZD4
  • Signaling by EGFR in Cancer
  • PCP/CE pathway
  • Adaptive Immune System
  • Mitotic Prophase
  • HIV Infection
  • Nuclear import of Rev protein
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Nuclear Envelope Breakdown
  • SLC-mediated transmembrane transport
  • M Phase
  • Influenza Life Cycle
  • HIV Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Rev-mediated nuclear export of HIV RNA
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Transcriptional regulation by small RNAs
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Host Interactions of HIV factors
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Hexose transport
  • Cell Cycle, Mitotic
  • Late Phase of HIV Life Cycle
  • Antiviral mechanism by IFN-stimulated genes
  • Viral Messenger RNA Synthesis
  • Metabolism of carbohydrates
  • Glucose transport
AP2B1 and SLC25A6 adaptor-related protein complex 2, beta 1 subunit solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6
  • Retrograde neurotrophin signalling
  • Axon guidance
  • HIV Infection
  • Nef Mediated CD8 Down-regulation
  • L1CAM interactions
  • Signaling by Wnt
  • Signaling by EGFRvIII in Cancer
  • Recycling pathway of L1
  • EPH-ephrin mediated repulsion of cells
  • MHC class II antigen presentation
  • EPH-Ephrin signaling
  • Nef Mediated CD4 Down-regulation
  • EGFR downregulation
  • Signalling by NGF
  • Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
  • Host Interactions of HIV factors
  • The role of Nef in HIV-1 replication and disease pathogenesis
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • beta-catenin independent WNT signaling
  • Signaling by EGFR
  • WNT5A-dependent internalization of FZD4
  • Signaling by EGFR in Cancer
  • PCP/CE pathway
  • Adaptive Immune System
  • Integration of energy metabolism
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • HIV Infection
  • Regulation of insulin secretion
  • Host Interactions of HIV factors
  • Mitochondrial protein import
  • Host Interactions with Influenza Factors
  • Influenza Infection
  • Influenza Virus Induced Apoptosis
  • Interactions of Vpr with host cellular proteins
  • Clodronate
AP2B1 and NUP54 adaptor-related protein complex 2, beta 1 subunit nucleoporin 54kDa
  • Retrograde neurotrophin signalling
  • Axon guidance
  • HIV Infection
  • Nef Mediated CD8 Down-regulation
  • L1CAM interactions
  • Signaling by Wnt
  • Signaling by EGFRvIII in Cancer
  • Recycling pathway of L1
  • EPH-ephrin mediated repulsion of cells
  • MHC class II antigen presentation
  • EPH-Ephrin signaling
  • Nef Mediated CD4 Down-regulation
  • EGFR downregulation
  • Signalling by NGF
  • Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
  • Host Interactions of HIV factors
  • The role of Nef in HIV-1 replication and disease pathogenesis
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • beta-catenin independent WNT signaling
  • Signaling by EGFR
  • WNT5A-dependent internalization of FZD4
  • Signaling by EGFR in Cancer
  • PCP/CE pathway
  • Adaptive Immune System
  • Mitotic Prophase
  • HIV Infection
  • Nuclear import of Rev protein
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Nuclear Envelope Breakdown
  • SLC-mediated transmembrane transport
  • M Phase
  • Influenza Life Cycle
  • HIV Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Rev-mediated nuclear export of HIV RNA
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Transcriptional regulation by small RNAs
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Host Interactions of HIV factors
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Hexose transport
  • Cell Cycle, Mitotic
  • Late Phase of HIV Life Cycle
  • Antiviral mechanism by IFN-stimulated genes
  • Viral Messenger RNA Synthesis
  • Metabolism of carbohydrates
  • Glucose transport
AES and RPL18A amino-terminal enhancer of split ribosomal protein L18a
  • APC truncation mutants have impaired AXIN binding
  • misspliced GSK3beta mutants stabilize beta-catenin
  • T41 mutants of beta-catenin aren't phosphorylated
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • AXIN missense mutants destabilize the destruction complex
  • TCF7L2 mutants don't bind CTBP
  • truncated APC mutants destabilize the destruction complex
  • S45 mutants of beta-catenin aren't phosphorylated
  • Signaling by Wnt
  • repression of WNT target genes
  • APC truncation mutants are not K63 polyubiquitinated
  • S37 mutants of beta-catenin aren't phosphorylated
  • Degradation of beta-catenin by the destruction complex
  • deletions in the AMER1 gene destabilize the destruction complex
  • AMER1 mutants destabilize the destruction complex
  • S33 mutants of beta-catenin aren't phosphorylated
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Signaling by WNT in cancer
  • truncations of AMER1 destabilize the destruction complex
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
AHR and IVNS1ABP aryl hydrocarbon receptor influenza virus NS1A binding protein
AHR and GTF2F1 aryl hydrocarbon receptor general transcription factor IIF, polypeptide 1, 74kDa
  • RNA Polymerase II Promoter Escape
  • mRNA Splicing
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • HIV Infection
  • Formation of the Early Elongation Complex
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • Influenza Life Cycle
  • HIV elongation arrest and recovery
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Influenza Viral RNA Transcription and Replication
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Viral Messenger RNA Synthesis
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
  • RNA Polymerase II Transcription Elongation
AHR and GTF2F2 aryl hydrocarbon receptor general transcription factor IIF, polypeptide 2, 30kDa
  • RNA Polymerase II Promoter Escape
  • mRNA Splicing
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • HIV Infection
  • Formation of the Early Elongation Complex
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • Influenza Life Cycle
  • HIV elongation arrest and recovery
  • HIV Transcription Initiation
  • HIV Life Cycle
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Influenza Viral RNA Transcription and Replication
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Viral Messenger RNA Synthesis
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
  • RNA Polymerase II Transcription Elongation
AHR and XPO1 aryl hydrocarbon receptor exportin 1
  • Loss of Function of TGFBR2 in Cancer
  • Downregulation of TGF-beta receptor signaling
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • TGF-beta receptor signaling activates SMADs
  • Influenza Life Cycle
  • Export of Viral Ribonucleoproteins from Nucleus
  • RNF mutants show enhanced WNT signaling and proliferation
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Host Interactions of HIV factors
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Influenza Infection
  • Late Phase of HIV Life Cycle
  • Resolution of Sister Chromatid Cohesion
  • Mitotic G2-G2/M phases
  • Mitotic Metaphase and Anaphase
  • Mitotic Prometaphase
  • Separation of Sister Chromatids
  • HIV Infection
  • Rev-mediated nuclear export of HIV RNA
  • G2/M Transition
  • Mitotic Anaphase
  • TGFBR1 LBD Mutants in Cancer
  • HuR stabilizes mRNA
  • deactivation of the beta-catenin transactivating complex
  • M Phase
  • HIV Life Cycle
  • Rev-mediated nuclear export of HIV RNA
  • Cyclin A/B1 associated events during G2/M transition
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • NEP/NS2 Interacts with the Cellular Export Machinery
  • Loss of Function of SMAD2/3 in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Interactions of Rev with host cellular proteins
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex
  • Signaling by TGF-beta Receptor Complex in Cancer
  • TCF dependent signaling in response to WNT
  • Signaling by WNT in cancer
  • SMAD4 MH2 Domain Mutants in Cancer
AHR and HSP90AA1 aryl hydrocarbon receptor heat shock protein 90kDa alpha (cytosolic), class A member 1
  • HSF1 activation
  • Regulatory RNA pathways
  • Signaling by EGFRvIII in Cancer
  • Regulation of PLK1 Activity at G2/M Transition
  • Influenza Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Uptake and actions of bacterial toxins
  • EPH-Ephrin signaling
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Recruitment of mitotic centrosome proteins and complexes
  • Regulation of actin dynamics for phagocytic cup formation
  • vRNP Assembly
  • Influenza Infection
  • Signaling by ERBB2
  • Signaling by VEGF
  • Signaling by EGFR in Cancer
  • Sema3A PAK dependent Axon repulsion
  • Mitotic G2-G2/M phases
  • Uptake and function of diphtheria toxin
  • PIWI-interacting RNA (piRNA) biogenesis
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Attenuation phase
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • HSF1-dependent transactivation
  • EPHA-mediated growth cone collapse
  • Metabolism of nitric oxide
  • VEGFR2 mediated vascular permeability
  • Loss of Nlp from mitotic centrosomes
  • Scavenging by Class F Receptors
  • eNOS activation and regulation
  • Innate Immune System
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Assembly of the primary cilium
  • Cellular response to heat stress
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • eNOS activation
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Centrosome maturation
  • Constitutive Signaling by EGFRvIII
  • Rifabutin
  • Nedocromil
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • Geldanamycin
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine
  • 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid
  • 17-Dmag
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine
  • Adenosine-5\'-Diphosphate
  • 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole
  • 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE
  • 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE
  • 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide
  • 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one
  • 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE
  • 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE
  • N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
  • 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol
  • 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL
  • 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
  • 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
  • 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
  • (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
  • 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-
  • 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
  • 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
  • 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
  • 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
  • 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine
  • 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE
  • 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE

Page 7 out of 89 pages